AEArlanna Esguerra-Lallen

Arlanna Esguerra-Lallen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arlanna Esguerra-Lallen has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • John F. Fraser

    Institute for Molecular Bioscience, The University of Queensland Brisbane Queensland Australia

    2 shared publications
  • John-Paul Tung

    Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia

    2 shared publications
  • Sanne Engkilde-Pedersen

    Strategic Transformation and Readiness, Australian Red Cross Lifeblood, PO Box 41, Everton Park, QLD, Australia, 4053; Critical Care Research Group (CCRG), The Prince Charles Hospital, 627 Rode Rd, Chermside, QLD, Australia, 4032; Adult Intensive Care Services, The Prince Charles Hospital, 627 Rode Rd, Chermside, QLD, Australia, 4032

    2 shared publications
  • Ai-Ching Boon

    Critical Care Research Group, Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia

    1 shared publication
  • Alexis J Perros

    Strategic Transformation and Readiness, Australian Red Cross Lifeblood, PO Box 41, Everton Park, QLD, Australia, 4053; Faculty of Medicine, University of Queensland, 20 Weightman St, Herston, QLD, Australia, 4006; School of Health, University of the Sunshine Coast, Locked Bag 4, Maroochydore DC, QLD, Australia, 4558; Critical Care Research Group (CCRG), The Prince Charles Hospital, 627 Rode Rd, Chermside, QLD, Australia, 4032

    1 shared publication
  • Annette Sultana

    Research and Development, Australian Red Cross Blood Service, Brisbane, Australia

    1 shared publication

Latest Publications

  • Open Access

    Cardiac surgery modulates leucocyte subsets and inflammatory mediators

    by Alexis J Perros, Kelly Rooks, Fenny Chong, Sanne Engkilde-Pedersen, Arlanna Esguerra-Lallen, Elise Hewlett, Helen M Faddy, Rishendran Naidoo, John-Paul Tung, John F Fraser, et al.

  • Open Access

    Inflammation and lung injury in an ovine model of fluid resuscitated endotoxemic shock

    by Margaret R. Passmore, Liam Byrne, Nchafatso G. Obonyo, Louise E. See Hoe, Ai-Ching Boon, Sara D. Diab, Kimble R. Dunster, Kavita Bisht, John-Paul Tung, Mohd H. Fauzi, et al.

    Sepsis is a multi-system syndrome that remains the leading cause of mortality and critical illness worldwide, with hemodynamic support being one of the cornerstones of the acute management of sepsis. We used an ovine model of endotoxemic shock to determine if 0.9% saline resuscitation contributes to lung inflammation and injury in acute respiratory distress syndrome, which is a common complication of sepsis, and investigated the potential role of matrix metalloproteinases in this process. Endotoxemic shock was induced in sheep by administration of an escalating dose of lipopolysaccharide, after which they subsequently received either no fluid bolus resuscitation or a 0.9% saline bolus. Lung tissue, bronchoalveolar fluid (BAL) and plasma were analysed by real-time PCR, ELISA, flow cytometry and immunohistochemical staining to assess inflammatory cells, cytokines, hyaluronan and matrix metalloproteinases. Endotoxemia was associated with decreased serum albumin and total protein levels, with activated neutrophils, while the glycocalyx glycosaminoglycan hyaluronan was significantly increased in BAL. Quantitative real-time PCR studies showed higher expression of IL-6 and IL-8 with saline resuscitation but no difference in matrix metalloproteinase expression. BAL and tissue homogenate levels of IL-6, IL-8 and IL-1β were elevated. This data shows that the inflammatory response is enhanced when a host with endotoxemia is resuscitated with saline, with a comparatively higher release of inflammatory cytokines and endothelial/glycocalyx damage, but no change in matrix metalloproteinase levels.